Refining the phenotype associated with MEF2C point mutations

被引:62
作者
Bienvenu, Thierry [1 ,2 ,3 ,5 ]
Diebold, Bertrand [3 ]
Chelly, Jamel [1 ,2 ,3 ]
Isidor, Bertrand [4 ]
机构
[1] Univ Paris 05, Lab Genet Malad Neurodev, Inst Cochin, CNRS UMR 8104, F-75014 Paris, France
[2] INSERM, U1016, Paris, France
[3] Hop Cochin, Assistance Publ Hop Paris, Lab Biochim & Genet Mol, F-75674 Paris, France
[4] CHU Nantes, Unite Genet Clin, F-44035 Nantes 01, France
[5] Univ Paris 05, Inst Cochin, Inserm U1016, F-75014 Paris, France
关键词
Mental retardation; Intellectual disability; MEF2C; Hand stereotypies; SEVERE MENTAL-RETARDATION; MICRODELETION; REGION;
D O I
10.1007/s10048-012-0344-7
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学];
摘要
Up to now, only five-point mutations in the MEF2C gene have been described in patients with severe mental retardation with absent speech, limited walking abilities, epilepsy, and lack of gross malformations. In brain, MEF2C is essential for early neurogenesis, neuronal migration, and differentiation. Here, we present a new patient with severe mental retardation, epilepsy, and hand stereotypies associated with a novel MEF2C frameshift mutation c.457delA. The purpose of this work was to clarify criteria for the selection of patients with severe intellectual disability to screen for deficiency in the MEF2C gene. By combining the clinical data of all patients with MEF2C point mutations published so far with the phenotype of our patient, a targeted search for MEF2C mutations could be applied to patients with a severe intellectual deficiency associated with absence of language and hypotonia, strabismus, and epilepsy (started after 6 months, often well controlled by valproate).
引用
收藏
页码:71 / 75
页数:5
相关论文
共 12 条
[1]
Transcription Factor 4 and Myocyte Enhancer Factor 2C Mutations are not Common Causes of Rett Syndrome [J].
Armani, Roksana ;
Archer, Hayley ;
Clarke, Angus ;
Vasudevan, Pradeep ;
Zweier, Christiane ;
Ho, Gladys ;
Williamson, Sarah ;
Cloosterman, Desiree ;
Yang, Nan ;
Christodoulou, John .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2012, 158A (04) :713-719
[2]
Periventricular heterotopia, mental retardation, and epilepsy associated with 5q14.3-q15 deletion [J].
Cardoso, C. ;
Boys, A. ;
Parrini, E. ;
Mignon-Ravix, C. ;
McMahon, J. M. ;
Khantane, S. ;
Bertini, E. ;
Pallesi, E. ;
Missirian, C. ;
Zuffardi, O. ;
Novara, F. ;
Villard, L. ;
Giglio, S. ;
Chabrol, B. ;
Slater, H. R. ;
Moncla, A. ;
Scheffer, I. E. ;
Guerrini, R. .
NEUROLOGY, 2009, 72 (09) :784-792
[3]
A novel microdeletion syndrome involving 5q14.3-q15: clinical and molecular cytogenetic characterization of three patients [J].
Engels, Hartmut ;
Wohlleber, Eva ;
Zink, Alexander ;
Hoyer, Juliane ;
Ludwig, Kerstin U. ;
Brockschmidt, Felix F. ;
Wieczorek, Dagmar ;
Moog, Ute ;
Hellmann-Mersch, Birgit ;
Weber, Ruthild G. ;
Willatt, Lionel ;
Kreiss-Nachtsheim, Martina ;
Firth, Helen V. ;
Rauch, Anita .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2009, 17 (12) :1592-1599
[4]
Functional regulatory regions of human transcription factor MEF2C [J].
Janson, CG ;
Chen, Y ;
Li, Y ;
Leifer, D .
MOLECULAR BRAIN RESEARCH, 2001, 97 (01) :70-82
[5]
Lambert L, 2012, CLIN GENET, DOI [10.1111/j.1399-0004.2012.01861, DOI 10.1111/J.1399-0004.2012.01861]
[6]
MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations [J].
Le Meur, N. ;
Holder-Espinasse, M. ;
Jaillard, S. ;
Goldenberg, A. ;
Joriot, S. ;
Amati-Bonneau, P. ;
Guichet, A. ;
Barth, M. ;
Charollais, A. ;
Journel, H. ;
Auvin, S. ;
Boucher, C. ;
Kerckaert, J-P ;
David, V. ;
Manouvrier-Hanu, S. ;
Saugier-Veber, P. ;
Frebourg, T. ;
Dubourg, C. ;
Andrieux, J. ;
Bonneau, D. .
JOURNAL OF MEDICAL GENETICS, 2010, 47 (01) :22-29
[7]
Phosphorylation of the MADS-box transcription factor MEF2C enhances its DNA binding activity [J].
Molkentin, JD ;
Li, L ;
Olson, EN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (29) :17199-17204
[8]
MEF2: a central regulator of diverse developmental programs [J].
Potthoff, Matthew J. ;
Olson, Eric N. .
DEVELOPMENT, 2007, 134 (23) :4131-4140
[9]
De Novo 5q14.3 Translocation 121.5-kb Upstream of MEF2C in a Patient With Severe Intellectual Disability and Early-Onset Epileptic Encephalopathy [J].
Saitsu, Hirotomo ;
Igarashi, Noboru ;
Kato, Mitsuhiro ;
Okada, Ippei ;
Kosho, Tomoki ;
Shimokawa, Osamu ;
Sasaki, Yuki ;
Nishiyama, Kiyomi ;
Tsurusaki, Yoshinori ;
Doi, Hiroshi ;
Miyake, Noriko ;
Harada, Naoki ;
Hayasaka, Kiyoshi ;
Matasumoto, Naomichi .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2011, 155A (11) :2879-2884
[10]
De Novo Microdeletion of 5q14.3 Excluding MEF2C in a Patient With Infantile Spasms, Microcephaly, and Agenesis of the Corpus Callosum [J].
Shimojima, Keiko ;
Okumura, Akihisa ;
Mori, Harushi ;
Abe, Shinpei ;
Ikeno, Mitsuru ;
Shimizu, Toshiaki ;
Yamamoto, Toshiyuki .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2012, 158A (09) :2272-2276